Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.
Healthline Daily News
Labcorp
November 18, 2026
Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes
 
READ ON
→
Trump's Prescription Drug Plan to Lower Prices of GLP-1s, Other High Cost Meds
 
READ ON
→
Most Effective Hair Loss Treatments In 2026, According to Experts
 
READ ON
→
3 Easy Homemade Creams for Eczema Relief
 
READ ON
→
MORE STORIES
 
 
 
  →
 
 
 
 
PRODUCT PICK
 
TODAY'S RESOURCE
 
What we’re reading next
• Everything You Need to Know About Lipotropic Injections
• Is Breast Cancer Curable? Get the Facts
• Factor Meals Review for 2027: How the Meals Looked, Tasted, and Scored
• 5 Immune-Boosting Soups for Cold and Flu Season
FOLLOW US ON INSTAGRAM
@healthline
healthline
fb   tiktok   X   youtube   insta